ATMW-2
ATMW-2 is a NeuralGenThesis (NGT) -derived antagonist targeting the melanocortin type 2 receptor (MC2R) .
Product Specifications
UNSPSC
12352005
Target
Melanocortin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/atmw-2.html
Smiles
COC1=CC=C(C(NC(COC2=CC=C(C=C2Cl)C3=CC=CC4=C3OCC4)=O)CN(C)C)C=C1
Molecular Formula
C27H29ClN2O4
Molecular Weight
480.98
References & Citations
[1]P de Oliveira SH, et al. NGT: Generative AI with Synthesizability Guarantees Discovers MC2R Inhibitors from a Tera-Scale Virtual Screen. J Med Chem. 2024 Nov 14;67 (21) :19417-19427.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15126233 1 Vial
Lentiviral human ZBTB10 shRNA (UAS) - Lentiviral human ZBTB10 shRNA (UAS) (25)
Sign In for Pricing
View Details 
orb1303612-01 1 mg
Protease-Activated Receptor-1, PAR-1 Agonist acetate
Sign In for Pricing
View Details orb1303612-02 5 mg
Protease-Activated Receptor-1, PAR-1 Agonist acetate
Sign In for Pricing
View Details orb1303612-03 10 mg
Protease-Activated Receptor-1, PAR-1 Agonist acetate
Sign In for Pricing
View Details orb1303612-04 25 mg
Protease-Activated Receptor-1, PAR-1 Agonist acetate
Sign In for Pricing
View Details orb1303612-05 50 mg
Protease-Activated Receptor-1, PAR-1 Agonist acetate
Sign In for Pricing
View Details